| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10495-016-1250-5 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s10495-016-1250-5 |
| P8608 | Fatcat ID | release_fuaa7pitlzbunfpy5ltyltvedu |
| P698 | PubMed publication ID | 27193464 |
| P2093 | author name string | Hongzhi Wang | |
| Xinyi Li | |||
| Peiqi Wang | |||
| Sijia Li | |||
| Lingyu Huang | |||
| Leilei Fu | |||
| Yuanyuan Yin | |||
| Chenyu Xiong | |||
| P2860 | cites work | G4LDB: a database for discovering and studying G-quadruplex ligands. | Q36491171 |
| NPACT: Naturally Occurring Plant-based Anti-cancer Compound-Activity-Target database | Q36491416 | ||
| Cancer treatment using peptides: current therapies and future prospects | Q36515785 | ||
| Exploring genetic interactions and networks with yeast | Q36825599 | ||
| Synthetic lethality: a framework for the development of wiser cancer therapeutics | Q37442913 | ||
| Synthetic therapeutic peptides: science and market | Q37625355 | ||
| An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules. | Q38275613 | ||
| Comprehensive transcriptomic analysis of molecularly targeted drugs in cancer for target pathway evaluation | Q38463905 | ||
| Managing Drug Resistance in Cancer: Role of Cancer Informatics. | Q38748135 | ||
| canSAR: an updated cancer research and drug discovery knowledgebase | Q38811457 | ||
| CancerResource--updated database of cancer-relevant proteins, mutations and interacting drugs | Q38817942 | ||
| SynLethDB: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets | Q38823713 | ||
| CancerPPD: a database of anticancer peptides and proteins. | Q38951733 | ||
| Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors | Q39988198 | ||
| dbEM: A database of epigenetic modifiers curated from cancerous and normal genomes. | Q40097436 | ||
| Development of a gene expression database and related analysis programs for evaluation of anticancer compounds. | Q42677922 | ||
| CancerProView: a graphical image database of cancer-related genes and proteins | Q43981840 | ||
| DrugBank 4.0: shedding new light on drug metabolism | Q24568341 | ||
| Cancer statistics, 2015 | Q27860576 | ||
| Synthetic lethality--a new direction in cancer-drug development | Q28249798 | ||
| BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology | Q28603124 | ||
| ChEMBL web services: streamlining access to drug discovery data and utilities | Q28647641 | ||
| The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity | Q29547693 | ||
| Systematic identification of genomic markers of drug sensitivity in cancer cells | Q29547695 | ||
| The NCI60 human tumour cell line anticancer drug screen | Q29614975 | ||
| Cancer drug resistance: an evolving paradigm | Q29616694 | ||
| PharmGKB: the Pharmacogenomics Knowledge Base | Q33855594 | ||
| Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells | Q34313686 | ||
| Drug resistance in cancer: an overview. | Q34437369 | ||
| C²Maps: a network pharmacology database with comprehensive disease-gene-drug connectivity relationships | Q34470187 | ||
| KISS1 methylation and expression as tumor stratification biomarkers and clinical outcome prognosticators for bladder cancer patients | Q35167858 | ||
| HDACiDB: a database for histone deacetylase inhibitors | Q35535409 | ||
| Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011. | Q35634845 | ||
| CancerHSP: anticancer herbs database of systems pharmacology. | Q35740846 | ||
| High-throughput screening against thioredoxin glutathione reductase identifies novel inhibitors with potential therapeutic value for schistosomiasis | Q35764981 | ||
| TaxKB: a knowledge base for new taxane-related drug discovery | Q35797139 | ||
| Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information | Q36434850 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 778-794 | |
| P577 | publication date | 2016-05-18 | |
| P1433 | published in | Apoptosis | Q15749546 |
| P1476 | title | Current situation and future usage of anticancer drug databases | |
| P478 | volume | 21 |
| Q38674530 | A review of drug-induced liver injury databases |
| Q49315568 | Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights. |
| Q55216429 | Cancer Drug Response Profile scan (CDRscan): A Deep Learning Model That Predicts Drug Effectiveness from Cancer Genomic Signature. |
| Q92940611 | Substance-Based Bibliometrics: Identifying Research Gaps by Counting and Analyzing Substances |
| Q42670070 | The additive effects of atorvastatin and insulin on renal function and renal organic anion transporter 3 function in diabetic rats |
Search more.